Company Overview
Meda is a specialty pharmaceutical company.
Executive Moves reported in July 2026 that Gary Bird, appointed Chief Executive Officer of LumaCina, had held senior roles at Meda during a pharmaceutical career spanning more than three decades in Australia and the Asia Pacific region.
This page is a light profile compiled from Executive Moves coverage. Founding detail, scale markers, listing venue and ownership have not yet been confirmed from a primary source and will be added as they are verified.
Recent Leadership News
MEDays Forum 2026 Set for Tangier, 25 to 28 November (July 2026).
Facts compiled by Executive Moves from publicly available news and press releases on 16 July 2026. Spotted an inaccuracy? Email us and we'll review within 1 business day.
To upgrade to a Premium Profile reach out to us at info@executive-moves.com.
Are you on the Meda team?
This is a Light company page, auto-generated from public news coverage. Claim it to verify the company description, add logo and links, and control how your organisation is represented on Executive Moves.
Claim this company →
